Cuál es el precio por CG Oncology Inc. (CGON)

Precio por CG Oncology Inc. (CGON) es de$78.86

Cuál es la capitalización de mercado por CG Oncology Inc. (CGON)

Capitalización de mercado por CG Oncology Inc. (CGON) es $6.96B

CG Oncology Inc. (CGON) Historial de Precios

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.

Año	Rendimiento
2026 (TTM)	34.54%
2025	32.36%
2024	0.00%

Año

Rendimiento

2026 (TTM)

34.54%

2025

32.36%

2024

0.00%

Empresa	Precio de la acción	Cambio 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$553.09	42.20%	US
Argenx SE ARGX.US	$1.02K	50.56%	NL
Moderna, Inc. MRNA.US	$158.64	525.80%	US
CSL Limited CSL.AX	$122.47	-12.71%	AU
Lonza Group AG LONN.SW	$772.27	8.67%	CH

Empresa

Precio de la acción

Cambio 1a%

País